Fact-checked by Grok 2 weeks ago

Heterotrimeric G protein

Heterotrimeric G proteins are nucleotide-binding regulatory proteins composed of three subunits—α, β, and γ—that serve as molecular switches to transduce extracellular signals from G protein-coupled receptors (GPCRs) to intracellular effectors, regulating diverse physiological processes such as sensory perception, hormone responses, and . These proteins function by cycling between an inactive GDP-bound state and an active GTP-bound state, where activation occurs upon GPCR-catalyzed nucleotide exchange, leading to subunit dissociation and effector modulation. The Gα subunit is the GTP-binding component, featuring a Ras-like GTPase domain and an α-helical domain that together form a nucleotide-binding cleft, while the and Gγ subunits form a stable, membrane-anchored dimer that associates with Gα in the resting state. binding to the GPCR induces a conformational change in the receptor that promotes its association with the inactive heterotrimer (Gα-GDP-βγ), catalyzing GDP release from Gα and GTP binding, causing dissociation into Gα-GTP and Gβγ, both of which can independently activate or inhibit downstream like , , or ion channels. Signaling terminates via the intrinsic activity of Gα, which hydrolyzes GTP to GDP, allowing re-association with Gβγ to reset the cycle. Heterotrimeric G proteins are categorized into four major families based on sequence and function of the Gα subunit: Gs (stimulates to increase ), Gi/o (inhibits and modulates ion channels), Gq/11 (activates to produce IP3 and DAG), and G12/13 (regulates Rho-mediated cytoskeletal dynamics). Humans express 16 Gα isoforms (from these families), 5 Gβ isoforms, and 12 Gγ isoforms, enabling promiscuous coupling where many GPCRs interact with multiple subtypes to fine-tune cellular responses. Dysregulation of these pathways is implicated in diseases such as cancer, , and neurological disorders, underscoring their therapeutic potential.

Molecular Composition

Subunit Structure

Heterotrimeric G proteins consist of three distinct subunits: α, β, and γ, each with unique structural features that contribute to their overall function. The α subunit is a globular protein comprising approximately 350–395 amino acids and exhibiting a molecular weight of 40–45 kDa. Its core structure includes a Ras-like GTP-binding domain (G domain) of about 200 amino acids, which harbors five highly conserved sequence motifs designated G1 through G5; these motifs facilitate guanine nucleotide binding, GTP hydrolysis, and magnesium coordination essential for the subunit's GTPase activity. Adjacent to the G domain is an α-helical domain (AHD) consisting of six α-helices that inserts into the nucleotide-binding pocket, thereby regulating access to GDP and GTP and modulating the rate of nucleotide exchange. For membrane localization, the α subunit undergoes N-terminal post-translational lipidation: myristoylation at glycine-2 in Gi/o family members or palmitoylation at cysteine-3 in Gs and Gq/11 families, which enhances affinity for the plasma membrane. The β subunit is a ~340-amino-acid protein with a molecular weight of 35–40 kDa, characterized by a seven-bladed β- fold formed by tandem repeats, each contributing four antiparallel β-strands to create a stable, rigid . This structure, with blades arranged symmetrically around a central , provides multiple surfaces for protein-protein while maintaining structural through conserved tryptophan-aspartate dipeptides at the motif termini. The N-terminal helix of the β subunit engages in a coiled-coil interaction with the γ subunit, forming a tight dimer that serves as the primary membrane-anchoring unit in the heterotrimer. In contrast, the γ subunit is the smallest component, typically 60–80 long with a molecular weight of 7–10 kDa, adopting an elongated, largely unstructured conformation except for its N-terminal helical region. Its contains a canonical CAAX motif (where C is , A is aliphatic, and X is variable), which directs : farnesylation for γ1 or geranylgeranylation for most other isoforms, followed by proteolytic and carboxyl to irreversibly tether the subunit to membranes. Within the inactive heterotrimer, the α-βγ interface is maintained by extensive contacts involving the α subunit's switch I/II regions onto the β propeller's top face via ionic bonds (e.g., involving conserved arginines and aspartates) and hydrophobic interactions, while the α-γ interface is more limited; this arrangement stabilizes the GDP-bound state and prevents premature dissociation. These subunit architectures are highly conserved across eukaryotes, reflecting their ancient evolutionary origin and fundamental role in .

Assembly and Heterotrimer Formation

Heterotrimeric G proteins are composed of α, β, and γ subunits that are synthesized separately on free ribosomes in the . The biogenesis of these subunits involves distinct folding pathways facilitated by molecular chaperones to ensure proper structure and function. For the Gα subunit, the chaperone Ric-8 plays a critical role in folding nascent polypeptides, promoting the formation of a nucleotide-free that is competent for subsequent GTP binding and heterotrimer incorporation. In contrast, Gβ folding is assisted by the cytosolic chaperonin containing TCP-1 () complex, which prevents aggregation, while the co-chaperone phosducin-like protein 1 (PhLP1) forms a transient ternary complex with and Gβ, enhancing dimerization with Gγ upon CK2-mediated phosphorylation of PhLP1. Gγ subunits, synthesized as precursors with a CaaX , associate rapidly with Gβ in the to form a stable βγ dimer within minutes of . Post-translational modifications are essential for membrane targeting and localization of the subunits to the plasma or internal compartments such as the (). Gα subunits undergo palmitoylation at an N-terminal residue, mediated by DHHC-family palmitoyl acyltransferases, which occurs dynamically in the ER or Golgi and facilitates reversible association; additionally, Gα subunits in the Gi/o family receive irreversible myristoylation at the N-terminal glycine via N-myristoyltransferase, enhancing affinity. The Gγ subunit is prenylated at its C-terminal CaaX by either farnesyltransferase (for Gγ1, Gγ9, Gγ11) or geranylgeranyltransferase (for other isoforms), followed by proteolytic cleavage of the -AAX residues by the ER-resident Rce1 and carboxyl by isoprenylcysteine carboxyl methyltransferase (Icmt), which collectively promote stable insertion into bilayers. These modifications not only anchor the subunits but also direct the βγ dimer to the cytoplasmic face of the ER, setting the stage for heterotrimer formation. Assembly of the heterotrimer begins with the formation of the cytosolic Gβγ dimer, which then binds to the nascent, modified Gα subunit to generate the inactive GDP-bound complex, primarily in the or Golgi apparatus. This process is chaperone-dependent, with Ric-8 potentially aiding Gα incorporation into the trimer by stabilizing its folded state, and the entire assembly is thought to occur prior to trafficking to the plasma membrane via a Golgi-independent pathway for some isoforms. In mammals, the combinatorial diversity arises from 16 Gα genes (encoding multiple isoforms via ), 5 Gβ genes, and 12 Gγ genes, allowing for nearly 1,000 potential heterotrimer combinations that enable specialized signaling. The G-protein cycle, involving activation and deactivation, contributes to recycling and maintenance of the heterotrimer pool at membranes. Defects in these assembly processes, such as impaired chaperone or failed lipid modifications, often result in subunit mislocalization and reduced signaling efficiency, as observed in cellular models of chaperone depletion. The stability of the assembled heterotrimer is maintained by high-affinity interactions in the GDP-bound state, with dissociation constants typically in the sub-nanomolar range (Kd ≈ 0.1–1 nM), ensuring the complex remains intact until receptor-mediated activation. Evolutionary conservation of assembly motifs, including the helical and domains of Gα and the repeats in Gβ, underscores the precision of this process across species. The tight binding between Gα-GDP and Gβγ, augmented by βγ's enhancement of Gα's GDP affinity, further stabilizes the inactive form prior to membrane integration.

Activation Mechanism

Interaction with GPCRs

G-protein-coupled receptors (GPCRs) are integral membrane proteins featuring seven α-helical transmembrane domains that span the , connected by three intracellular loops and three extracellular loops, with the extracellular and the intracellular. The ligand-binding pocket, typically located within the transmembrane bundle, accommodates diverse such as hormones, neurotransmitters, and photons. Upon binding, the GPCR undergoes a conformational change that enables it to function as a (GEF), facilitating the release of GDP from the Gα subunit of the associated heterotrimeric G protein to allow GTP binding. The molecular interface for G protein docking is primarily mediated by the intracellular face of the GPCR. The C-terminal α5 helix of the Gα subunit penetrates deeply into the receptor's cytoplasmic core, forming extensive contacts with the helical bundle, particularly involving residues in transmembrane helices 3, 5, and 6, as revealed by the crystal structure of the β₂-adrenergic receptor (β₂AR) in complex with Gs. Additionally, the Gβγ complex makes auxiliary contacts with the GPCR's intracellular loops, particularly loops 2 and 3, stabilizing the overall interaction and contributing to the alignment of the Gα nucleotide-binding site. These interactions position the G protein such that the receptor can allosterically disrupt GDP binding on Gα. Agonist binding induces a key outward tilt and rotation of transmembrane helix 6 (TM6) by approximately 14 Å at its cytoplasmic end, which expands the intracellular cavity and creates the primary docking site for the . This movement, conserved across class A GPCRs, propagates from the ligand-binding pocket through the transmembrane core to the intracellular side, enabling productive engagement with the heterotrimer. Coupling specificity is dictated largely by the sequence of the Gα , which varies among Gα families and fits into distinct pockets on the receptor; for instance, the extreme C-terminal residues of Gαs interact uniquely with the β₂AR core, ensuring selective activation over other Gα subtypes. The interaction between GPCRs and G proteins was first demonstrated in the 1980s through pioneering reconstitution experiments by Edwin M. Ross and colleagues, who purified the β-adrenergic receptor and Gs components and showed hormone-dependent activation of adenylate cyclase, establishing the direct receptor- link. Subsequent photolabeling studies in the late 1980s using azido derivatives confirmed proximity between receptor intracellular domains and G protein subunits. Quantitatively, the activated GPCR enhances the rate of GDP/GTP exchange on Gα by 10³- to 10⁵-fold compared to the basal rate, which is about 0.0001 s⁻¹ without receptor , underscoring the receptor's role in overcoming the intrinsic stability of the Gα-GDP interaction.

GDP-GTP Exchange

In the inactive state of heterotrimeric G proteins, (GDP) binds tightly to the Gα subunit with a (K_d) in the picomolar range (approximately 10 ), stabilizing a closed conformation where the α-helical domain (AHD) of Gα covers the Ras-like guanine nucleotide-binding domain (G domain). This high-affinity interaction prevents spontaneous nucleotide release under physiological conditions. Upon activation, an agonist-bound (GPCR*) interacts with the heterotrimeric Gαβγ-GDP complex, acting as a (GEF) to catalyze GDP release. The GPCR stabilizes an open conformation of Gα by promoting separation of the AHD from the G domain (up to ~30 Å), which reduces GDP affinity and allows its dissociation. Intracellular GTP, present at concentrations approximately 10-fold higher than GDP (~0.5 mM vs. ~0.05 mM), then binds rapidly to the nucleotide-free Gα, favoring GTP loading over GDP rebinding. The intrinsic rate of GDP release from Gαβγ is extremely slow, on the order of 0.0001–0.0002 s⁻¹ (e.g., k_off ≈ 0.0002 s⁻¹ for Gαo), limiting basal activity. GPCR catalysis dramatically accelerates this exchange rate by 10³- to 10⁵-fold, achieving 0.1–50 s⁻¹ turnover depending on the Gα isoform and receptor, enabling rapid . The intrinsic GTP hydrolysis rate ( activity) varies by Gα family, approximately 0.05 min⁻¹ for Gαs and faster (~0.1–4 min⁻¹) for Gαi/o at ~20°C, which ultimately deactivates Gα-GTP. Key structural elements facilitate this process: a conserved arginine residue in the switch II region of Gα (e.g., Arg²⁰¹ in Gαs) interacts with the GPCR intracellular core, stabilizing the open conformation and aiding GDP ejection, while a conserved glutamine in the G3 motif (part of the DXXGQ sequence) helps position the γ-phosphate of incoming GTP for binding. These interactions are supported by structural studies of GPCR-G protein complexes. The overall catalytic cycle can be simplified as: \text{G}\alpha\beta\gamma\text{-GDP} + \text{GPCR}^* \rightarrow \text{GPCR}^* \cdot \text{G}\alpha\beta\gamma\text{-GDP} \rightarrow \text{GPCR} + \text{G}\alpha\text{-GTP} + \beta\gamma This sequence leads to heterotrimer , with Gα-GTP and free Gβγ signaling to downstream effectors until GTP reforms the inactive Gαβγ-GDP complex. Experimental evidence from confirms the mechanistic importance of nucleotide handling. For instance, the Q227L mutation in Gαs (corresponding to Gln⁶¹ in ) impairs intrinsic activity, locking Gαs in the GTP-bound active state and causing constitutive stimulation, as observed in GH3 pituitary cells and gsp oncogene-associated tumors. Similar studies with α5 mutations further demonstrate slowed exchange rates when domain opening is restricted, underscoring the role of conformational dynamics in .

Effector Interactions

Alpha Subunit Functions

Upon binding GTP, the α subunit of heterotrimeric G proteins undergoes a significant conformational change, exposing the Switch I, II, and III regions critical for effector binding while the α-helical domain opens to facilitate interactions. This GTP-bound state dissociates from the βγ complex, enabling the free Gα-GTP to engage downstream effectors and propagate signaling. The diversity of effectors targeted by GTP-bound Gα reflects the functional specialization of Gα families. In the G_s family, Gα_s activates through its TCAT motif, stimulating production. Conversely, Gα_i from the G_i family inhibits or directly binds G protein-gated inwardly rectifying potassium (GIRK) channels to modulate ion flux. For the G_q family, Gα_q activates C-β (PLC-β) via contacts involving its α-helical domain, leading to hydrolysis of into second messengers. Members of the G_{12/13} family activate Rho guanine exchange factors (e.g., p115RhoGEF), promoting RhoA activation and cytoskeletal reorganization. These interactions can be represented as: \text{G}\alpha\text{-GTP + Effector} \to \text{signaling} Gα subunits maintain membrane localization through N-terminal lipid modifications, such as myristoylation (common in G_i family) or palmitoylation (in G_s and G_q), which anchor the protein to the plasma membrane and support trafficking to effectors including ion channels. Signaling by GTP-bound Gα is terminated via its intrinsic GTPase activity, which hydrolyzes GTP to GDP and inorganic phosphate (P_i), reverting Gα to an inactive conformation that reassociates with βγ: \text{G}\alpha\text{-GTP} \to \text{G}\alpha\text{-GDP + P_i} The hydrolysis rate varies across families, typically in the range of 0.5–4 min⁻¹ at 30 °C, with effective signaling duration further modulated by regulators of G protein signaling (RGS proteins), which act as GTPase-activating proteins (GAPs) to accelerate hydrolysis up to 1000-fold by stabilizing the transition state. For instance, G_s signaling is often prolonged due to limited RGS regulation. Bacterial toxins exemplify modulation of Gα GTPase function. Cholera toxin ADP-ribosylates Gα_s at Arg201, inhibiting and locking the subunit in its active state to constitutively activate . Similarly, pertussis toxin ADP-ribosylates Gα_i at Cys351, preventing GPCR interaction and thereby blocking of the inhibitory pathway.

Beta-Gamma Complex Functions

Upon of heterotrimeric G proteins by G protein-coupled receptors (GPCRs), the βγ complex dissociates from the GTP-bound Gα subunit and diffuses laterally within the plasma membrane, enabling interactions with downstream effectors via exposed binding sites on the β subunit surface, including switch regions in the structure. These "hot spots," such as the top-facing Interface I and side-facing Interface II, facilitate specific protein-protein contacts that regulate signaling fidelity. The free βγ dimer directly activates several key effectors to propagate signals. It binds to and opens G protein-gated inwardly rectifying (GIRK) channels through interactions at the channel's intracellular , promoting potassium efflux and cellular hyperpolarization, as demonstrated in structural studies (PDB: 4KFM). βγ stimulates class I phosphoinositide 3-kinases (PI3K), particularly the Gβγ-sensitive PI3Kγ (p110γ/p101) isoform, by recruiting it from the to the and enhancing its lipid kinase activity to produce phosphatidylinositol 3,4,5-trisphosphate. It also allosterically activates phospholipase C-β (PLC-β) isozymes via multiple binding sites, including the pleckstrin homology , leading to hydrolysis of into inositol 1,4,5-trisphosphate and diacylglycerol. Additionally, βγ inhibits voltage-gated calcium channels (e.g., N-type and P/Q-type) by direct binding, thereby reducing calcium influx and modulating processes like release. Beyond effector activation, the βγ complex plays critical regulatory roles in signal termination and organization. It recruits GPCR kinases (GRKs), such as GRK2/3, to the membrane by binding their regulator of G protein signaling (RGS) domains (PDB: 1OMW), enabling GRK-mediated of activated GPCRs and promoting β-arrestin for desensitization and . βγ also acts as a scaffold for multiprotein signaling complexes, for instance, by facilitating interactions with (PKC) through of γ subunit residues like Ser1 in Gγ12, which enhances PKC translocation and activity. The functional specificity of βγ signaling arises from the combinatorial diversity of its subunits—five β isoforms and twelve γ isoforms—which allows tailored interactions in different tissues and cellular compartments. of the γ subunit's C-terminal CAAX motif (farnesylation or geranylgeranylation) is indispensable for membrane association and access to lipid-embedded effectors, as non-prenylated βγ fails to activate membrane-bound targets effectively. The of βγ are rapid, with half-lives on the order of seconds (e.g., ~9–12 s for translocation or dissociation events), and reassociation with GDP-bound Gα is driven by high-affinity interactions to terminate signaling. Experimentally, overexpression of βγ subunits in cells mimics Gi/o-mediated activation, such as enhancing GIRK currents or PLC activity independent of Gα, confirming its autonomous signaling role. Many βγ-effector interactions, including those with PLC-β and novel scaffolds like RACK1, were first identified in the 1990s using yeast two-hybrid screens with βγ as bait.

Subunit Diversity

Alpha Subunit Families

Heterotrimeric G proteins in mammals are categorized into four primary alpha subunit families—Gs, Gi/o, Gq/11, and G12/13—based on sequence homology, GTPase activity, and interactions with downstream effectors. This classification reflects functional specialization, with alpha subunits within each family sharing 30-50% sequence identity, while inter-family homology is lower, around 20-30%. The diversity arises from gene duplications that occurred approximately 500 million years ago during early vertebrate evolution, leading to the expansion of 16 distinct human GNA genes encoding these subunits. The Gs family, represented by the gene product, activates to increase cyclic AMP levels, playing a broad role in stimulatory signaling pathways. The active GTP-bound state of Gs alpha is prolonged due to limited interaction with regulators of signaling (RGS) proteins compared to other families. In contrast, the Gi/o family, encompassing eight subtypes including GNAI1, GNAI2, GNAI3, GNAO1, GNAZ, GNAT1, GNAT2, and GNAT3, primarily inhibits and influences potassium channels and adenylyl cyclase isoforms. A key structural hallmark of Gi/o subunits is a conserved residue near the (e.g., Cys-351 in GNAI1), which serves as the target for by , thereby uncoupling these subunits from receptors. The Gq/11 family, including genes like GNAQ and GNA11, activates phospholipase C-β (PLC-β) to generate and diacylglycerol, mobilizing intracellular calcium. These subunits possess a distinctive in the GTPase domain that facilitates specific binding to PLC-β isoforms. Meanwhile, the G12/13 family, encoded by GNA12 and GNA13, regulates Rho guanine nucleotide exchange factors to modulate cytoskeletal dynamics and . Evolutionary conservation underscores the ancient origins of these families, with orthologs present in simpler eukaryotes; for instance, the GPA1 encodes a functionally analogous to the family, where the GTP-bound form sequesters the beta-gamma complex to suppress signaling. Expression patterns of alpha subunits are often tissue-specific, enhancing signaling precision; Gs is ubiquitously expressed across most cell types to support basal regulation, whereas Gz (GNAZ) is predominantly found in neuronal tissues, including brain regions involved in and platelet aggregation.

Beta and Gamma Subunits

In mammals, there are five isoforms of the β subunit encoded by the GNB1 through GNB5 genes, sharing greater than 90% sequence identity across their core domains. These isoforms each adopt a characteristic toroidal structure composed of seven β-propeller blades, which serves as a scaffold for interactions with other components and effectors. Despite their high similarity, subtle differences in surface residues lead to variations in effector affinities; for instance, the β1 isoform, often paired with γ2, exhibits a preference for activating G protein-gated inwardly rectifying (GIRK) channels. The γ subunits display greater diversity, with 12 isoforms encoded by genes including GNG1 through GNG5, GNG7 through GNG8, GNG10 through GNG13, GNGT1, and GNGT2, showing less than 30% identity among some variants. A key structural feature is the C-terminal CAAX motif, which undergoes with either a farnesyl (15-carbon) or geranylgeranyl (20-carbon) isoprenoid group, influencing membrane association and subcellular localization. For example, the γ1 isoform is farnesylated and primarily targets the plasma membrane, while isoforms like γ2 are geranylgeranylated, promoting stronger membrane anchoring and potential for distinct compartmentalization, such as translocation to internal membranes upon signaling. The combinatorial assembly of β and γ subunits yields approximately 60 possible βγ dimers, given the 5 β and 12 γ isoforms, which expand the functional diversity of G protein signaling by modulating α subunit selectivity and intracellular trafficking. Specific pairings, such as β1γ2 with Gi family α subunits, enhance coupling efficiency to certain receptors and effectors while directing the complex to appropriate cellular locations via prenylation-driven membrane interactions. Evolutionarily, the β subunit is highly conserved, tracing back to the yeast ortholog Ste4p involved in mating pheromone response, whereas γ subunits exhibit more variability, likely adapting to specialized roles in compartmentalized signaling across species. Notably, βγ dimers interact with β-arrestins, which can sequester them to facilitate receptor desensitization and prevent sustained signaling. studies underscore the physiological importance of specific isoforms; for example, homozygous disruption of GNB1 is embryonic lethal in mice, highlighting its essential role in development, including cardiac tissue where β1 is highly expressed.

Physiological Roles

In Mammalian Systems

Heterotrimeric G proteins play pivotal roles in mammalian by transducing signals from G protein-coupled receptors (GPCRs) across diverse pathways, including sensory perception, hormonal control, neural communication, and metabolic . In mammals, these proteins enable precise regulation of cellular responses to external stimuli, such as and odors, as well as internal cues like hormones and neurotransmitters, through subunit-specific interactions that amplify and diversify signaling cascades. The diversity of G protein subunits allows for tailored specificity in these processes, ensuring context-dependent outcomes in various tissues. In sensory , heterotrimeric G proteins are essential for converting environmental stimuli into electrical signals. In , transducin (Gt, composed of Gαt subunits) in and photoreceptors of the couples to and cone opsins upon light activation, stimulating phosphodiesterase 6 (PDE6) to hydrolyze cGMP, which closes cGMP-gated channels and hyperpolarizes the cell. This mechanism underlies phototransduction, with Gαt1 predominant in rods and Gαt2 in cones, as evidenced by impaired light responses in Gαt-deficient mice. In olfaction, Gi/o family proteins, particularly Gαolf, in the cilia of olfactory sensory neurons bind to odorant receptors (ORs), activating III to elevate levels, which opens cyclic nucleotide-gated channels and depolarizes the neuron. Gαolf-deficient models exhibit , highlighting its critical role in odor detection. Hormonal regulation relies on G proteins to modulate metabolic and vascular responses. The Gs family, coupled to the in hepatocytes and renal cells, promotes activation upon binding, elevating to stimulate (PKA) and enhance and for glucose . In smooth muscle, Gq/11 subunits, activated by receptors like angiotensin II type 1 (AT1R) or α1-adrenergic receptors, trigger phospholipase C-β (PLC-β) to generate inositol 1,4,5-trisphosphate (IP3), releasing intracellular calcium and inducing vasoconstriction to maintain . Neural functions of G proteins encompass synaptic modulation and cytoskeletal dynamics. Gi/o proteins in presynaptic terminals inhibit and, via βγ subunits, suppress voltage-gated calcium channels, thereby reducing release and synaptic . G12/13 members, through activation of Rho guanine exchange factors (RhoGEFs) like p115RhoGEF, stimulate RhoA to reorganize the actin , facilitating neuronal cell migration and during development. In , G proteins contribute to endocrine and cardiovascular balance. Gi subunits, particularly Gαi2, inhibit in insulin-sensitive tissues, modulating insulin signaling to regulate and prevent excessive cAMP-mediated counter-regulation. For cardiovascular tone, βγ complexes from Gi/o proteins directly activate G protein-gated inwardly rectifying potassium (GIRK) channels in the , hyperpolarizing cardiomyocytes to slow heart rate in response to parasympathetic input, as demonstrated in Gαi2 knockout models showing . Approximately 800 GPCRs interact with heterotrimeric proteins to orchestrate these physiological processes, underscoring their broad impact. Disruptions in protein signaling influence around 35% of FDA-approved drugs, which primarily target GPCRs to modulate these pathways. Recent advances, including post-2020 single-molecule imaging studies, have revealed compartmentalized protein signaling in primary cilia, where spatiotemporal dynamics of GPCRs and receptors like are confined to ciliary compartments, enhancing signal fidelity in sensory and developmental contexts.

In Plants and Other Organisms

Heterotrimeric G proteins in exhibit a simplified composition compared to animals, with the Arabidopsis thaliana encoding a single canonical Gα subunit (GPA1, which is Gi-like), one Gβ subunit (AGB1), and three Gγ subunits (AGG1, AGG2, and the atypical AGG3). Unlike animal systems, lack large families of canonical G protein-coupled receptors (GPCRs); instead, signaling is modulated by seven-transmembrane regulator of G protein signaling (RGS) proteins, such as AtRGS1, which accelerate on GPA1 to control deactivation. In , GPA1 regulates , as evidenced by reduced formation in gpa1 mutants, and stomatal closure through (ROS) production in response to (ABA). The Gβγ complex, particularly AGB1 with AGG1/AGG2, activates (MAPK) cascades to enhance defense against necrotrophic pathogens. In fungi, heterotrimeric G proteins play conserved roles in mating and development, exemplified by the pheromone response pathway in budding yeast (Saccharomyces cerevisiae). Here, the Gα subunit Gpa1 (Gi-like) maintains an inhibitory state by sequestering the Gβγ dimer (Ste4/Ste18) until pheromone binding to the GPCR Ste2/Ste3 promotes GDP-GTP exchange, releasing Gβγ to activate downstream effectors like the MAPK cascade for mating. Similarly, in the social amoeba Dictyostelium discoideum, G proteins mediate chemotaxis to cyclic AMP (cAMP), where multiple Gα subunits (including Gα2) couple with cAMP receptors to activate pathways involving PI3K and MAPK for directed cell migration during aggregation. Evolutionarily, plant G proteins diverged early from animal orthologs, lacking clear Gs and Gq family equivalents; GPA1 clusters with Gi/o, reflecting adaptations to sessile lifestyles with self-activating mechanisms independent of traditional GPCRs. The atypical Gγ subunit AGG3 exemplifies this divergence, influencing organ size and seed development in Arabidopsis, where agg3 knockouts exhibit smaller seeds and reduced organ growth due to altered cell proliferation. In non-mammalian animals like Caenorhabditis elegans, G proteins show reduced diversity with 21 Gα (including goa-1, a Gi/o ortholog), two Gβ, and two Gγ subunits—fewer β and γ than in mammals—yet goa-1 negatively regulates locomotion and synaptic transmission via dopamine signaling.

Clinical Significance

Role in Diseases

Dysregulation of heterotrimeric G proteins through genetic mutations contributes to various disorders, particularly those involving impaired signaling in endocrine and neurological systems. Inactivating mutations in the gene, which encodes the Gαs subunit, lead to type Ia, characterized by resistance to and other hormones due to reduced Gsα activity and consequent low levels. Conversely, activating somatic mutations in cause and McCune-Albright syndrome by promoting constitutive Gsα signaling, resulting in excessive production and abnormal bone development. Gain-of-function variants in GNAO1, encoding Gαo, are associated with early-onset epileptic and , where hyperactive Gαo disrupts regulation and neuronal excitability. Oncogenic mutations in G protein subunits drive tumorigenesis by sustaining proliferative signaling pathways. Activating mutations in GNAQ or GNA11, which encode Gαq family members, occur in approximately 80-90% of uveal melanomas and constitutively activate the MAPK pathway downstream of PKC, promoting and survival. These mutations lock Gαq/11 in a GTP-bound state, leading to persistent IP3 and DAG production. exploit heterotrimeric G proteins to cause disease by targeting their regulatory cycles. In , produces that ADP-ribosylates the Gαs subunit at 201, inhibiting its activity and locking it in an active state, which causes massive elevation in intestinal cells and severe secretory . Similarly, in , secretes that ADP-ribosylates Gαi subunits, preventing their interaction with receptors and thereby inhibiting Gi-mediated suppression of , leading to uncontrolled signaling and respiratory symptoms. Neurological diseases arise from disruptions in G protein trafficking and signaling. Mutations in TOR1A, encoding torsinA, cause early-onset primary by impairing the protein's role in endoplasmic reticulum-associated degradation and vesicular trafficking in striatal neurons. Epidemiological data highlight the prevalence of G protein alterations in disease. Mutations in G protein-encoding genes occur in about 1-5% of human cancers, with GNAS variants enriched in endocrine tumors and GNAQ/GNA11 in melanomas. Recent studies have linked GNAI2 polymorphisms to salt-sensitive , where reduced Gαi2 activity impairs regulation via altered adrenergic signaling. At the mechanistic level, many disease-associated G protein mutations impair activity, leading to constitutive signaling and aberrant second messenger production. GTPase-deficient mutants in Gαs elevate levels, disrupting and responses, while similar defects in Gαq increase IP3 and calcium mobilization, fostering pathological .

Therapeutic Targeting

Heterotrimeric G proteins are key targets in , with approximately 35% of approved drugs acting on G protein-coupled receptors (GPCRs) to modulate downstream G protein signaling. These GPCR-targeted therapies indirectly influence G protein activation by altering receptor conformation and guanine nucleotide exchange. For instance, beta-blockers such as antagonize β-adrenergic receptors, thereby inhibiting Gs-mediated activation and reducing cyclic AMP levels in cardiac tissue to treat and arrhythmias. Similarly, opioid agonists like bind μ-opioid receptors to activate Gi/o proteins, suppressing and inhibiting release for pain relief. Direct modulation of G proteins bypasses GPCRs and has emerged as a strategy to fine-tune signaling. Regulators of G protein signaling (RGS) proteins accelerate the intrinsic GTPase activity of Gα subunits, terminating signaling; thus, RGS proteins are pursued as therapeutic targets to enhance deactivation in overactive pathways, with small-molecule inhibitors developed to block RGS-Gα interactions. For Gq-mediated pathologies, particularly in cancer where oncogenic Gq mutations sustain signaling, selective inhibitors like YM-254890 have shown promise in preclinical models by locking Gq in an inactive GDP-bound state, though clinical translation remains limited. The βγ complex, often overlooked, is targeted by antagonists such as gallein, which binds the Gβγ hot spot to disrupt interactions with effectors like PI3K, reducing and in models of acute . Additionally, phage display-derived peptides, such as QEHA, selectively bind Gβγ to inhibit effector coupling at interfaces like those with GRK2, offering potential for cardiovascular and therapies. Challenges in G protein targeting include receptor desensitization from prolonged orthosteric ligand exposure, prompting development of allosteric modulators that bind intracellular GPCR-G protein interfaces to bias coupling without inducing internalization. Advances post-2022 leverage AI-driven design for small molecules selective to undruggable families like G12/13, which promote Rho-mediated oncogenesis; computational models have generated candidates that stabilize inactive conformations, enhancing efficacy in fibrosis and cancer models. A prominent clinical example is fingolimod, a sphingosine-1-phosphate receptor 1 (S1P1) modulator that internalizes the receptor to prevent Gi-mediated lymphocyte egress, approved for multiple sclerosis (MS).

References

  1. [1]
    Regulation, Signaling and Physiological Functions of G-proteins
    Heterotrimeric G-proteins mainly relay the information from G-protein-coupled receptors (GPCRs) on the plasma membrane to the inside of cells to regulate ...
  2. [2]
    Structural basis of function in heterotrimeric G proteins - PubMed
    This article reviews the structural determinants of the function of heterotrimeric G proteins in mammalian systems at each point in the G-protein cycle.
  3. [3]
    G protein-coupled receptors (GPCRs): advances in structures ...
    Apr 10, 2024 · Once activated by exogenous stimuli, GPCRs primarily employ heterotrimeric G-proteins and arrestins as transducers to produce second messengers ...<|control11|><|separator|>
  4. [4]
    Heterotrimeric G-proteins: a short history - PMC - PubMed Central
    The heterotrimeric guanine nucleotide-binding proteins (G-proteins) function to transduce signals from this vast panoply of receptors to effector systems.Early Days · Extending The Gα-Protein... · Understanding The Mechanism...
  5. [5]
    Gs Alpha Subunit - an overview | ScienceDirect Topics
    The mammalian α subunits are between 40 and 90% identical in amino acid sequence, and their overall length varies between 350 and 395 residues. The 16 α ...Missing: weight | Show results with:weight
  6. [6]
    Signal Activation and Inactivation by the Gα Helical Domain
    May 29, 2012 · The G protein α subunit is composed of two domains, one that resembles Ras and another that is composed entirely of α helices.
  7. [7]
    Plasma Membrane Localization of Gα z Requires Two Signals
    Oct 13, 2017 · Three covalent attachments anchor heterotrimeric G proteins to cellular membranes: the α subunits are myristoylated and/or palmitoylated, ...
  8. [8]
    Phylogenetic, Structural and Functional Relationships between WD ...
    The first structure determination of a WD-repeat protein was that of Gβ, the beta subunit of a heterotrimeric G-protein complex-and this structure revealed the ...
  9. [9]
    Separation and Analysis of G Protein γ Subunits - ScienceDirect
    The γ subunits are the smallest of the three subunits ranging in molecular mass from 7000 to 9000 kDa. To date 12 γ isoforms have been cloned, but further ...
  10. [10]
    G protein gamma subunits with altered prenylation sequences are ...
    The gamma subunits of heterotrimeric G proteins undergo post-translational prenylation and carboxylmethylation after formation of the betagamma dimer, ...Missing: weight | Show results with:weight
  11. [11]
    Heterotrimeric G‐proteins: a short history - 2006 - Wiley Online Library
    Feb 2, 2009 · The heterotrimeric guanine nucleotide-binding proteins (G-proteins) function to transduce signals from this vast panoply of receptors to effector systems.
  12. [12]
    Assembly and Trafficking of Heterotrimeric G Proteins - PMC - NIH
    This review will highlight new insights into how nascent G protein subunits are assembled and how they arrive at plasma membranes.
  13. [13]
  14. [14]
  15. [15]
    Computational modeling reveals how interplay between ... - PNAS
    The extent of G protein activation reflects the balance between the rates of GDP ... G-GDP (reaction D–1 = 0.0001 s–1). However, R can no longer increase Z and v ...
  16. [16]
    Structural Basis for Nucleotide Exchange in Heterotrimeric G Proteins
    Aug 1, 2016 · We find that the G protein α subunit Ras and helical domains—previously observed to separate widely upon receptor binding to expose the ...
  17. [17]
    Gαs slow conformational transition upon GTP binding and a novel ...
    ... GDP release from Gα on their binding to G proteins (Figure 1A). Given the approximately 10-fold higher concentration of GTP than GDP in the cell, GTP ...
  18. [18]
    Insights into G Protein Structure, Function, and Regulation
    The Gβ-subunit of heterotrimeric G proteins has a β-propeller structure containing seven WD-40 repeats (Ref. 7 and Fig. 2A). The Gγ-subunit interacts with the ...
  19. [19]
    Activation of G proteins by GTP and the mechanism of Gα-catalyzed ...
    In reconstituted vesicles containing Gα, Gβγ, a GPCR and the appropriate RGS protein or effector-GAP, GTP turnover rates can be 1000-fold higher than intrinsic ...
  20. [20]
    Article A universal allosteric mechanism for G protein activation
    Apr 1, 2021 · Upon GTP binding, switch II forms a well-ordered helix and makes multiple contacts with residues in the α3 helix. Switches I and II interact ...
  21. [21]
    GH3 cells expressing constitutively active Gs alpha (Q227L) show ...
    GH3 cells possessing Q227L have a higher proliferation rate and secrete higher levels of prolactin and growth hormone which are associated with higher levels ...
  22. [22]
    Conformational dynamics of a G-protein α subunit is tightly ... - PNAS
    Jun 13, 2016 · The Gα subunit has two structural domains, a nucleotide-binding domain (the Ras-like domain) and a helical domain (the α-H domain) that ...
  23. [23]
    Mapping allosteric connections from the receptor to the nucleotide ...
    Heterotrimeric G protein α subunits function in the cell as molecular switch proteins, cycling between an inactive GDP-bound heterotrimeric conformation and an ...Mapping Allosteric... · Results · Discussion
  24. [24]
    The Quest to Understand Heterotrimeric G Protein Signaling - NIH
    Switch II forms a major component of the interface, as it does in other characterized effector complexes. The Gαsubunit has a slow GTPase activity that converts ...
  25. [25]
    Structures of Gα Proteins in Complex with Their Chaperone Reveal ...
    To achieve these post-translational modifications, we utilized a ... heterotrimeric G protein a subunits. Proc. Natl. Acad. Sci. USA 110, 3794 ...
  26. [26]
    G(alpha)(i) controls the gating of the G protein-activated K ... - PubMed
    GIRK (Kir3) channels are activated by neurotransmitters coupled to G proteins, via a direct binding of G(beta)(gamma). The role of G(alpha) subunits in GIRK ...
  27. [27]
    The Roles of Gβγ and Gα in Gating and Regulation of GIRK Channels
    Gα(i/o) also binds to GIRKs and has been implicated in regulating channel's gating, in concert with Gβγ. Among known functions of Gα, best-described (though not ...
  28. [28]
    Mechanism of Activation and Inactivation of Gq/Phospholipase C-β ...
    The major binding determinants for activated Gαq are found just outside the N- and C-terminal ends of the C2 domain of PLC-β isozymes. ... α-helix of activated ...
  29. [29]
    Lipid Modifications of Trimeric G Proteins (∗)
    Jan 13, 1995 · This minireview will address recent advances in understanding how fatty acylation regulates the cellular localization and function of G proteins.<|control11|><|separator|>
  30. [30]
    Membrane Trafficking of Heterotrimeric G Proteins via the ...
    The CAAX motifs of Gγ can be either farnesylated (Gγ1) or geranylgeranylated (most other Gγ subunits) (Wedegaertner et al., 1995). Analysis of the sequences of ...Missing: weight | Show results with:weight
  31. [31]
    RGS4 and GAIP are GTPase-activating proteins for Gqα and ... - PNAS
    We demonstrate here that two RGS proteins, RGS4 and GAIP, also act as GAPs for Gqα, the Gα protein responsible for activation of phospholipase Cβ. Furthermore, ...
  32. [32]
    Cholera toxin: A paradigm of a multifunctional protein - PMC
    The 22kD A1 domain of CT (CTA1) catalyzes the transfer of the ADP-ribose moiety of NAD+ to an Arginine residue (Arg201) of the α subunit of Gs, leading to ...
  33. [33]
    adrenoceptor: G(alphai1) protein-mediated pertussis toxin-resistant ...
    Expression of either the wild-type G(alphai1) or mutant G(alphai1)Cys(351)Gly protein in co-expression or fusion with the alpha(2A)-adrenoceptor in COS-7 cells ...
  34. [34]
  35. [35]
    Roles of G beta gamma in membrane recruitment and ... - PubMed
    Jan 6, 2003 · The class IB p110 gamma/p101 PI3K gamma is activated by G beta gamma on stimulation of G protein-coupled receptors. It is currently unknown ...Missing: GIRK PLC
  36. [36]
    G protein gamma subunit, a hidden master regulator of GPCR ...
    On translocating, some βγ complexes act on effectors in internal membranes. The variation in translocation kinetics determines differential sensitivity and ...
  37. [37]
    The βγ Subunit of Heterotrimeric G Proteins Interacts with RACK1 ...
    A yeast two-hybrid approach was used to discern possible new effectors for the βγ subunit of heterotrimeric G proteins.
  38. [38]
    Gα 12/13 signaling in metabolic diseases - Nature
    Jun 23, 2020 · Based on the characteristics of the Gα subunit, heterotrimeric G proteins are classified into four families: Gαs (s represents stimulation), Gαi ...
  39. [39]
    Tracing the evolution of the heterotrimeric G protein α subunit in ...
    Apr 11, 2018 · Heterotrimeric G proteins are fundamental signaling proteins composed of three subunits, Gα and a Gβγ dimer. The role of Gα as a molecular ...
  40. [40]
    Major events in the genome evolution of vertebrates - PNAS
    The distribution of inferred ages of duplicated genes shows a similar increase in the number of duplication events ≈675 mya, as observed in Fugu. As expected, ...
  41. [41]
    Structure, Function, Pharmacology, and Therapeutic Potential of the ...
    Mar 24, 2015 · ... G proteins consisting of three subunits termed alpha, beta, and gamma. G proteins are classified into four families according to their α subunit ...
  42. [42]
    Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin ...
    The A-protomer catalyzes the ADP-ribosylation of a cysteine residue in the α subunit of the heterotrimeric Gi/o protein subfamily, whereas the B-oligomer is ...
  43. [43]
    Structural design principles that underlie the multi-specific ... - Nature
    May 3, 2019 · Gαq is a ubiquitous molecular switch that activates the effectors phospholipase-C-β3 (PLC-β3) and Rho guanine-nucleotide exchange factors.
  44. [44]
    Heterotrimeric G Protein-coupled Receptor Signaling in Yeast ... - NIH
    Genetic studies and biochemical analysis have demonstrated that Ste2 and Ste3 are coupled to the same heterotrimeric G protein, composed of Gpa1/Scg1 (Gα) and ...
  45. [45]
    Identification of a region in G protein γ subunits conserved ... - NIH
    The γ subunits are the least similar of the G protein subunits, with <30% identity among some isoforms, in contrast to the β subunits, which have >90% identity ...
  46. [46]
  47. [47]
    Evidence that neuronal G-protein-gated inwardly rectifying K+ ...
    Jul 3, 1995 · Here we report that GIRK2 but not GIRK3 can be activated by G protein subunits G beta 1 and G gamma 2 in Xenopus oocytes. Furthermore, when ...
  48. [48]
    Comprehensive analysis of heterotrimeric G-protein complex ...
    Heterotrimer combinations consisting of αsL, β1–4, and γ1–13 were tested for their interaction with TM86V L167R in a coimmunoprecipitation experiment.
  49. [49]
    G protein gamma subunit, a hidden master regulator of GPCR ...
    Oct 19, 2022 · A four-residue conserved amino acid sequence called; “the CaaX motif” on the C terminus of the γ subunit determines the type of prenylation ...
  50. [50]
    G-protein signaling leverages subunit-dependent membrane affinity ...
    G-protein activation releases the βγ-complex from the α-subunit. The single lipid group on the γ-subunit imparts transient membrane binding, and free βγ- ...
  51. [51]
    Specificity of G protein beta and gamma subunit interactions - PubMed
    Jul 15, 1992 · The results indicate that beta 1 binds both gamma subunits, beta 2 binds only gamma 2, and beta 3 will bind neither gamma 1 or gamma 2.Missing: combinatorial trafficking
  52. [52]
    The STE4 and STE18 genes of yeast encode potential β and γ ...
    We propose that the products of the STE4 and STE18 genes comprise the β and γ subunits of a G protein complex coupled to the mating pheromone receptors. The ...
  53. [53]
    Sequestration of Gβγ by deubiquitinated arrestins into the nucleus ...
    Jan 19, 2023 · Desensitization at the receptor level is usually referred to as uncoupling, and is explained by GRK-mediated receptor phosphorylation and ...
  54. [54]
    Human GNB1 knockout HeLa cell line (ab264689) - Abcam
    With an approximate mass of 37 kDa GNB1 is expressed in numerous tissues throughout the human body including the central nervous system heart and spleen.
  55. [55]
  56. [56]
  57. [57]
    Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes ...
    The glucagon receptor (GCGR) is abundantly expressed by hepatocytes and is the most extensively studied Gs-coupled GPCR in the liver [25]. GCGR is activated by ...2.1. Glucagon Receptor · 2.3. Beta-Adrenergic... · 4.4. Free Fatty Acid...
  58. [58]
    Role of G-protein coupled receptors in cardiovascular diseases - PMC
    Jun 5, 2023 · GPCRs regulate blood pressure by modulating the dynamic balance of vasoconstriction and relaxation (113, 114). Gαq/11-coupled GPCRs and Gα12/13- ...
  59. [59]
    Regulation and Physiological Functions of G12/13-Mediated ...
    Accumulating evidence indicates that G12/13-mediated signaling pathways are involved in a variety of physiological processes, including embryonic development, ...
  60. [60]
    The Role of Inhibitory G Proteins and Regulators ... - PubMed Central
    The activation of cell signaling pathways involving inhibitory heterotrimeric G proteins acts to slow the heart rate via modulation of ion channels. A large ...Key Ion Channels · Atrial Fibrillation · Figure 2<|separator|>
  61. [61]
    Genome-wide pan-GPCR cell libraries accelerate drug discovery
    GPCRs account for about 40% of FDA-approved drugs, representing the most successful drug targets. However, only approximately 15% of the 800 human GPCRs are ...
  62. [62]
    G Protein-Coupled Receptors as Targets for Approved Drugs - NIH
    We estimate that ∼700 approved drugs target GPCRs, implying that approximately 35% of approved drugs target GPCRs.
  63. [63]
    Single-molecule imaging in the primary cilium - PMC
    Here, we outline how single-molecule fluorescence microscopy can be used for tracking molecular dynamics and interactions and for super-resolution imaging of ...Missing: compartmentalized | Show results with:compartmentalized
  64. [64]
    Heterotrimeric G Protein–Coupled Signaling in Plants - PMC - NIH
    Studies using rice and Arabidopsis have revealed the molecular plasticity of G signaling and pointed to novel mechanisms that control the activation state.Missing: paper | Show results with:paper
  65. [65]
    Four key signaling pathways mediating chemotaxis in Dictyostelium ...
    Feb 25, 2008 · G protein signaling events are activated at the leading edge of chemotactic cells. Cell. 95. : 81. –91. Crossref · Search ADS · PubMed. Pitt, ...
  66. [66]
    The fifth class of Gα proteins - PMC - PubMed Central - NIH
    Feb 3, 2009 · All α-subunits of vertebrate heterotrimeric G proteins have been classified into 4 major classes, Gs, Gi, Gq, and G12, which possess orthologs
  67. [67]
    Heterotrimeric G proteins in C. elegans - WormBook - NCBI - NIH
    Oct 13, 2006 · Heterotrimeric G proteins, composed of α, β, and γ subunits, are able to transduce signals from membrane receptors to a wide variety of intracellular effectors.Missing: fewer | Show results with:fewer
  68. [68]
    Functional characterization of GNAS mutations found in ... - PubMed
    Pseudohypoparathyroidism type Ia (PHPIa) is caused by GNAS mutations leading to deficiency of the α-subunit of stimulatory G proteins (Gsα) that mediate signal ...
  69. [69]
    Fibrous Dysplasia / McCune-Albright Syndrome - NCBI - NIH
    Feb 26, 2015 · Fibrous dysplasia / McCune-Albright syndrome (FD/MAS) results from mosaic somatic activating pathogenic variants in GNAS, which encodes the cAMP ...
  70. [70]
    Movement disorder in GNAO1 encephalopathy associated with gain ...
    Aug 22, 2017 · The GNAO1 LOF mutations are associated with epileptic encephalopathy while GOF mutants (such as G42R, G203R, and E246K) or normally functioning mutants (R209) ...
  71. [71]
    GNAQ and GNA11 Genes: A Comprehensive Review on ... - NIH
    The GNAQ and GNA11 genes are mutated in almost 80–90% of uveal melanomas in a mutually exclusive pattern. These genes encode the alpha subunits of the ...
  72. [72]
    Clinical and genetic study of ABCB4 gene-related cholestatic liver ...
    Apr 12, 2024 · Cholestatic liver diseases related to ABCB4 variants include progressive familial intrahepatic cholestasis type 3 (PFIC3), benign recurrent ...
  73. [73]
    Enhanced Sensitivity to Cholera Toxin in ADP-Ribosylarginine ... - NIH
    Cholera toxin (CT) produced by Vibrio cholerae causes the devastating diarrhea of cholera by catalyzing the ADP-ribosylation of the α subunit of the intestinal ...
  74. [74]
    DYT-TOR1A dystonia: an update on pathogenesis and treatment
    It is a severe genetic form of dystonia caused by mutations in the TOR1A gene. TorsinA is a member of the AAA + family of adenosine triphosphatases (ATPases) ...
  75. [75]
    Delta opioid receptors engage multiple signaling cascades to ...
    Opioids regulate circuits associated with motivation and reward across the brain. Of the opioid receptor types, delta opioid receptors (DORs) appear to have ...
  76. [76]
    Update on GNA Alterations in Cancer: Implications for Uveal ...
    Jun 10, 2020 · Least mutated (<1%) were glioma, lymphoma and germinal cell cancers. With a 4% rate, GNAS is the most frequently altered G protein-encoding gene ...2. Heterotrimeric G Proteins · 3. Mutations In Genes... · 3.1. Gnas Mutants
  77. [77]
    GNAI2 polymorphic variance associates with salt sensitivity of blood ...
    These observations suggest that genotyping at GNAI2 may be a useful biomarker in identifying individuals at risk for developing salt-sensitive BP and related ...Missing: variants 2023
  78. [78]
    GNAS spectrum of disorders - PMC - PubMed Central
    Mutations of GNAS that cause constitutive Gsα signaling are found in patients with McCune-Albright syndrome, fibrous dysplasia of bone, and different endocrine ...
  79. [79]
    G-Protein–Coupled Receptors in Heart Disease | Circulation Research
    Aug 30, 2018 · GPCRs (G-protein [guanine nucleotide-binding protein]–coupled receptors) play a central physiological role in the regulation of cardiac function in both health ...<|separator|>
  80. [80]
    Molecular insights into GPCR mechanisms for drugs of abuse
    Aug 17, 2023 · We herein review recent structural studies and provide insights into the molecular mechanisms of opioids, cannabinoids, and psychedelics at their respective ...
  81. [81]
    Regulators of G protein signaling (RGS) Proteins as Drug Targets
    Regulator of G protein signaling (RGS) proteins are emerging as important negative modulators of G protein-coupled receptor (GPCR) signaling.Missing: gallium Gq
  82. [82]
    Heterotrimeric G q proteins as therapeutic targets?
    Mar 2, 2020 · Specifically, we will single out a subset of Gq protein activities, namely aberrant signaling in cancer, to advance the ideas on drug–G protein ...Missing: gallium | Show results with:gallium
  83. [83]
    Gallein, a Gβγ subunit signalling inhibitor, inhibits metastatic spread ...
    Oct 30, 2017 · Gallein inhibits the spread of metastases in vivo and cell invasiveness in vitro, especially in cells expressing OR51E2 and exposed to β-ionone.Missing: phage display peptides
  84. [84]
    Understanding Molecular Recognition by G protein βγ Subunits on ...
    Gβγ subunits use a flexible 'hot spot' with a circular β-bladed propeller structure to interact with many proteins, using multiple bonding interactions.Missing: antagonist | Show results with:antagonist
  85. [85]
    CRISPR Clinical Trials: A 2024 Update - Innovative Genomics Institute
    Mar 13, 2024 · This phase 1 trial was sponsored by CRISPR Therapeutics and ViaCyte and was the first use of CRISPR to treat an endocrine disease. However ...Missing: melanoma | Show results with:melanoma
  86. [86]
    A genome-wide CRISPR screen unveils the endosomal maturation ...
    Here, using a CRISPR screen, we investigated intracellular proteins involved in ASOs efficiency using a whole genome approach and identified several potential ...Missing: GNAS GNAQ
  87. [87]
    Designing allosteric modulators to change GPCR G protein ... - Nature
    Oct 22, 2025 · G-protein-coupled receptors (GPCRs) convert extracellular signals into intracellular responses by signalling through 16 subtypes of Gα ...
  88. [88]
    [PDF] The Application of Artificial Intelligence Accelerates G Protein ...
    Oct 17, 2023 · Deep learning algorithm-based methods have assisted ligand optimization by generating novel molecular structures with desired properties. [22,23] ...<|separator|>
  89. [89]
    Sphingosine‐1‐Phosphate Receptor Modulators for the Treatment ...
    The efficacy and safety of fingolimod were evaluated in three Phase 3 trials in adults with relapsing‐remitting MS [23, 24, 25] and in pediatric patients ...
  90. [90]
    Sphingosine 1-phosphate receptor 1 modulators exert ... - Frontiers
    May 13, 2025 · Animal experiments and clinical trials have been conducted to assess the efficacy and safety of fingolimod for the treatment of ALS. A study ...